Pluang models what a $1,000 stake in Lilly could become by 2031, assuming 12.85% yearly returns after the drugmaker's revenue surge.
Recap by typeshit. Full story at Pluang.
Keltie Knight shares a personal take on body image pressure on women, tagged with GLP-1 and BookTok. It's a short social clip with few specifics.
8:41
The weekly tirzepatide update marks a milestone for the channel, with the scale finally dipping below 220 pounds.
Dr. Salas-Whalen makes the case that stepping down on a GLP-1 dose can be as important as going up. Her view, not a protocol.
A short link post on what patients should keep in mind as options for semaglutide and tirzepatide keep shifting. Details are at the source.
Dr. Alo says the heart benefit isn't just a byproduct of weight loss. That's his view, posted on social, not a new study.
A short teaser comparing how well people tolerate the two main GLP-1 ingredients, with the full breakdown behind the link.
Loading…